Lung cancer drug already available on NHS could cut bladder deaths
A lung cancer drug already available on the NHS has been proven to cut bladder cancer deaths and reduce the risk of the ...
FDA Approves AstraZeneca's Calquence Combo Therapy For Untreated Mantle Cell Lymphoma
AstraZeneca's Calquence gains FDA approval for untreated mantle cell lymphoma, supported by data showing improved survival and reduced disease progression.
securingindustry.com12d
WHO warns of falsified AstraZeneca cancer drug
The counterfeit versions of the cancer immunotherapy Imfinzi have been found in Armenia, Lebanon, and Türkiye.
Daily Mail6d
How bladder cancer patients are more likely to survive with a 'game-changer' immunotherapy drug
Durvalumab (brand name Imfinzi) is a treatment for non small cell lung cancer (NSCLC) but is also being trialled in other cancers. James Catto, professor of urology at the University of Sheffield ...
FierceBiotech3d
OS Therapies' HER2 drug prevented lung cancer from returning in a 3rd of patients
The therapy, dubbed OST-HER2, uses a HER2-bioengineered form of the bacteria Listeria monocytogenes to trigger an immune ...
The Independent on MSN5d
‘Game changer’ immunotherapy drug could lead to increased survival rates for bladder cancer patients
The study found that patients with muscle-invasive bladder cancer had significantly less risk of cancer progressing or ...
Targeted Oncology10d
FDA Clears Investigational New Drug Application for REC-4539 in SCLC
The FDA cleared the investigational new drug application for REC-4539, allowing for the start of a phase 1/2 trial in small ...
The Independent5d
Bladder cancer: Symptoms to look out for and when to see a doctor
Immunotherapy drug durvalumab, sold under the brand name Imfinzi, could help reduce the risk of bladder cancer progressing or returning to patients, according to a new study. Patients were given ...